ArticleArchives of toxicology2026
Embryotoxicity of pyrethroid insecticides and their mixtures in a human induced pluripotent stem cell-based model in vitro.
Article in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pyrethroid insecticides are used worldwide, yet their potential effects on early human development remain poorly understood. We applied the PluriLum assay, a human induced pluripotent stem cell-based 3D in vitro model, to evaluate the embryotoxicity of three commonly used pyrethroids (α-cypermethrin, deltamethrin, and etofenprox), and their shared metabolite 3-phenoxybenzoic acid (3-PBA). Embryoid bodies (EBs) were repeatedly exposed to these compounds throughout their differentiation into cardiomyocytes, and effects on cardiomyocyte beating, expression of the early cardiac marker NKX2.5, as well as their impact at a transcriptional level was assessed. The three pyrethroids were tested in combination at two different mixture compositions to investigate their potential for additivity. All three pyrethroids impaired cardiomyocyte differentiation at micromolar levels, with the following potency ranking: α-cypermethrin > etofenprox > deltamethrin. At higher concentrations, α-cypermethrin also reduced cardiomyocyte contractility. In contrast, 3-PBA showed no significant effects on neither differentiation nor contractile function. The pyrethroid mixtures followed the principle of concentration addition. An exploratory transcriptomic analysis revealed that α-cypermethrin and deltamethrin significantly altered the EBs gene expression profiles, affecting pathways related to ion channel activity, receptor signalling, and extracellular matrix organization. These findings suggest that exposure to pyrethroids may interfere with early human cardiac development through effects on multiple molecular targets. This study also highlights the value of the PluriLum assay as a human-relevant platform for assessing the embryotoxic potential of environmental chemicals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.